Apimeds Pharmaceuticals US, Inc. (APUS)

NYSEAMERICAN: APUS · Real-Time Price · USD

1.906

+0.046 (2.47%)

At close: Sep 5, 2025, 4:00 PM

1.850

-0.056 (-2.94%)

Pre-market: Sep 8, 2025, 8:50 AM EDT

APUS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	24	-	-	-	-
Enterprise Value	16	-	-	-	-
Debt / Equity Ratio	0.05	-0.50	8.38	-0.96	-1.68
Quick Ratio	10.80	0.00	3.33	0.02	16.09
Current Ratio	12.79	0.01	3.42	0.02	16.16
Return on Assets (ROA)	-42.42%	-366.30%	-218.17%	-448.25%	-
Return on Capital (ROIC)	-45.40%	-	-348.55%	-611.12%	-
Buyback Yield / Dilution	-28.67%	-71.89%	-19.55%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q